{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:09:15Z","timestamp":1720609755060},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9437-17","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T22:24:32Z","timestamp":1513808672000},"page":"861-866","source":"Crossref","is-referenced-by-count":4,"title":["Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules"],"prefix":"10.2169","volume":"57","author":[{"given":"Tsuyoshi","family":"Muta","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, Japan Community Health Care Organization (JCHO) Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Yoshihiro","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Jinnouchi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Japan Community Health Care Organization (JCHO) Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kochi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Japan Community Health Care Organization (JCHO) Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kyushu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Foley B, Cooley S, Verneris MR, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C<sup>+<\/sup> natural killer cells with potent function. Blood 119: 2665-2674, 2012.","DOI":"10.1182\/blood-2011-10-386995"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Takenaka K, Nishida T, Asano-Mori Y, et al. Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation. Biol Blood Marrow Transplant 21: 2008-2016, 2015.","DOI":"10.1016\/j.bbmt.2015.07.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cichocki F, Cooley S, Davis Z, et al. CD56<sup>dim<\/sup>CD57<sup>+<\/sup>NKG2C<sup>+<\/sup> NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia 30: 456-463, 2016.","DOI":"10.1038\/leu.2015.260"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103: 2474-2479, 2004.","DOI":"10.1182\/blood-2003-09-3080"},{"key":"5","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V84.7.2315.2315","volume":"84","author":"TC Gentile","year":"1994","unstructured":"5. Gentile TC, Uner AH, Hutchison RE, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 84: 2315-2321, 1994.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 29: 1284-1293, 2005.","DOI":"10.1097\/01.pas.0000173238.17331.6b"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115: 1026-1036, 2010.","DOI":"10.1182\/blood-2009-06-227579"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Iqbal J, Wright G, Wang C, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123: 2915-2923, 2014.","DOI":"10.1182\/blood-2013-11-536359"},{"key":"9","unstructured":"9. Kato S, Takahashi E, Asano N, et al. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Histopathology 61: 186-199, 2012."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kewalramani T, Zelenetz AD, Teruya-Feldstein J, et al. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma. Br J Haematol 134: 202-207, 2006.","DOI":"10.1111\/j.1365-2141.2006.06164.x"},{"key":"11","unstructured":"11. Loirat M, Chevallier P, Leux C, et al. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center. Ann Oncol 26: 386-392, 2015."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Rodrigues CA, Rocha V, Dreger P, et al. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood. Haematologica 99: 370-377, 2014.","DOI":"10.3324\/haematol.2013.088997"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Della Chiesa M, Falco M, Podest\u00e0 M, et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 119: 399-410, 2012.","DOI":"10.1182\/blood-2011-08-372003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Heath J, Newhook N, Comeau E, et al. NKG2C (+) CD57 (+) natural killer cell expansion parallels cytomegalovirus-specific CD8 (+) T cell evolution towards senescence. J Immunol Res 2016 (Epub ahead of print).","DOI":"10.1155\/2016\/7470124"},{"key":"15","unstructured":"15. Ohata K, Espinoza JL, Lu X, et al. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen. Biol Blood Marrow Transplant 17: 205-213, 2011."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kordelas L, Steckel NK, Horn PA, et al. The activating NKG2C receptor is significantly reduced in NK cells after allogeneic stem cell transplantation in patients with severe graft-versus-host disease. Int J Mol Sci 17: pii: E1797, 2016.","DOI":"10.3390\/ijms17111797"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. R\u00f6lle A, Pollmann J, Ewen EM, et al. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C<sup>+<\/sup> NK cell expansion. J Clin Invest 124: 5305-5316, 2014.","DOI":"10.1172\/JCI77440"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Reddy V, Winer AG, Eksioglu E, et al. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11: 1014-1021, 2005.","DOI":"10.1016\/j.bbmt.2005.08.032"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mar\u00edn R, Ruiz-Cabello F, Pedrinaci S, et al. Analysis of HLA-E expression in human tumors. Immunogenetics 11: 767-775, 2005.","DOI":"10.1007\/s00251-002-0526-9"},{"key":"20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cei.12785","volume":"185","author":"AB Bigley","year":"2016","unstructured":"20. Bigley AB, Rezvani K, Shah N, et al. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin Exp Immunol 185: 239-251, 2016.","journal-title":"Clinical & Experimental Immunology","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/6\/57_9437-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T16:38:37Z","timestamp":1603557517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/6\/57_9437-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9437-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}